Ashmore Group PLC

ASHM.L Q2 2026

Reported: 2026-02-17

Ashmore Group reported a solid performance in H1 '26, characterized by strong investment returns and growth in assets under management, despite a decline in revenues due to lower performance fees.

Key takeaways

Assets under management increased by 10% to approximately $52 billion, driven by net inflows of $2 billion.
Profit before tax soared 64% year-on-year to GBP 82 million, with diluted earnings per share up 90% to 10p.
The local offices, especially in emerging markets like Colombia and Indonesia, contributed significantly to AUM growth and overall diversification.
Despite a 16% decline in adjusted net revenue, cost management efforts kept total operating costs stable, highlighting operational efficiency.
The company maintained its interim dividend at 4.8p per share, signaling confidence in its financial stability.

View recap

BlueScope Steel Limited

BLSFY Q2 2026

Reported: 2026-02-17

BlueScope reported a strong first half with underlying EBIT of $558 million, reflecting a $249 million increase year-over-year, and remains committed to maximizing shareholder value through significant cash returns and operational enhancements.

Key takeaways

Underlying EBIT rose to $558 million, driven by diversified portfolio strength and stable ROIC of 8.1%.
The company plans to distribute $3 per share in returns in the 2026 calendar year, increasing the shareholder payout target to 75% of free cash flow.
BlueScope anticipates second half underlying EBIT between $620 million and $700 million, supported by stronger U.S. steel spreads and improved sales volumes.
Major projects, including the North Star debottlenecking and new metal coating line, are progressing well, positioning the company for future growth.
BlueScope initiated a new $150 million cost reduction program, aiming for a simpler and more agile operational structure.

View recap

Canaccord Genuity Group Inc.

CF.TO Q3 2026

Reported: 2026-02-17

Canaccord Community Group, Inc. reported strong Q3 fiscal 2026 results, with revenue reaching $616 million, up 37% year-over-year, driven by robust performance in both Wealth Management and Capital Markets.

Key takeaways

Firm-wide pretax net income surged 103% year-over-year to $81 million, translating to adjusted EPS of $0.36.
Capital Markets revenue increased by 43% year-over-year to $301 million, fueled by strong mining sector activity and new issue activity.
Wealth Management revenue grew by 30%, bolstered by a 154% increase in investment banking revenue following strategic acquisitions.
Client assets reached a record $145 billion, driven by growth across all geographic regions.
The sale of the U.S. wholesale market-making business is expected to streamline operations and enhance focus on M&A and investment banking services.

View recap

RH

DND.TO Q2 2026

Reported: 2026-02-17

Dye & Durham reported solid fundamentals in Q2 Fiscal 2026, focusing on operational scaling and integration to address historical challenges. The company plans a multi-year transformation to unify its legal software portfolio and enhance customer value.

Key takeaways

Identified $15M to $20M in annualized EBITDA savings through structural efficiency initiatives, with 60% expected by year-end.
Strategy pivots towards product integration and simplification to improve operational leverage, customer retention, and revenue per customer.
Launch of Unity in British Columbia signals efforts to modernize offerings and enhance customer engagement.
Historical reliance on acquisitions has led to fragmentation and decreased customer focus, necessitating a transition to a unified global platform.
Continued emphasis on balancing cost reductions while reinvesting in product development to drive sustainable growth.

View recap

Deterra Royalties Limited

DRR.AX Q2 2026

Reported: 2026-02-17

Deterra Royalties delivered a strong performance in the first half of 2026, reporting record net profit after tax of $87 million, supported by robust sales volumes and pricing from its Mining Area C royalty.

Key takeaways

Achieved a 12% increase in revenue driven by record sales of 68 million dry tonnes from Mining Area C, at a realized price of AUD 139 per tonne.
Successfully sold noncore precious metals assets for $108 million, contributing to a reduction in net debt to $149 million.
Declared a fully franked interim dividend of $0.124 per share, maintaining a 75% payout ratio consistent with prior periods.
Strong balance sheet with $344 million in undrawn credit facilities, enhancing strategic investment flexibility.
Significant progress on the Thacker Pass project, including the first draw on a U.S. Department of Energy loan, further derisking future cash flow potential.

View recap

HIVE Digital Technologies Ltd.

HIVE Q3 2026

Reported: 2026-02-17

HIVE Digital Technologies Ltd. posted remarkable growth in its Bitcoin production, achieving a 191% year-over-year increase, despite market volatility and heightened mining difficulty.

Key takeaways

Increased operational capacity with exahash growth from 6 to 25 in 2025, contributing to a 2% global network share.
Significant cost efficiency improvements noted, with joules per terahash reducing to just 17.5 from over 300 ten years ago.
Strong resilience against market downturns aided by economies of scale and prudent management practices.
Continued strategic growth anticipated into 2026, supported by a solid balance sheet and innovative technology transitions.
Market volatility presents an investment opportunity, with comparisons drawn to historical price fluctuations in other asset classes.

View recap

Macmahon Holdings Limited

MAH.AX Q2 2026

Reported: 2026-02-17

Macmahon's first half of 2026 demonstrated strong growth, with revenue increasing 11% to $1.3 billion and a marked improvement in underlying EBITDA and EBITA, reflecting the successful integration of civil infrastructure and mining operations into its growth strategy.

Key takeaways

Revenue increased by 11% to $1.3 billion, driven by robust contributions from both mining and civil infrastructure sectors.
Underlying EBITDA rose 10% to $200 million, alongside a 17% increase in EBITA to $91 million, positioning the company for strong full-year results.
The interim dividend was increased to $0.0095 per share, highlighting confidence in sustained earnings growth and cash flow generation, supported by a free cash flow of $39.3 million.
A strong order book amounting to $5.1 billion and a tender pipeline of $25.6 billion signals positive prospects for future revenue, with 50% expected to be awarded in the next 12 months.
Significant improvement in ROACE to 21.2%, underscoring effective capital allocation strategies and diversification efforts in core sectors.

View recap

Medtronic plc

MDT Q3 2026

Reported: 2026-02-17

Medtronic demonstrated robust performance in its latest quarter, reporting an 11% year-over-year revenue growth, driven significantly by innovation in cardiovascular and neurological segments.

Key takeaways

The Cardiovascular portfolio achieved 11% revenue growth, with CAS growing a staggering 80% year-over-year.
The Hugo robot received FDA clearance for urologic procedures, marking a significant step in its U.S. market entry with early installations at hospitals like Cleveland Clinic.
The introduction of Altaviva for urge urinary incontinence has garnered strong initial interest, reflecting effective direct-to-consumer marketing efforts.
Stealth AXiS surgical system has received FDA clearance, enhancing Medtronic's capabilities in spinal procedures and expanding their leadership in surgical navigation.
Continued focus on innovation is expected to drive sustained growth across high-need categories, with new product launches in the pipeline.

View recap

Palatin Technologies, Inc.

PTN Q2 2026

Reported: 2026-02-17

Palatin Pharmaceuticals reported revenue growth in Q2 FY2026, driven by collaborations, while significantly enhancing its balance sheet through a successful public offering. Net losses increased as the company invested heavily in advancing its obesity-focused drug pipeline.

Key takeaways

Completed an upsized public offering raising $18.2 million, restoring compliance with NYSE listing standards.
Revenue for the quarter was $116,000, marking a significant increase from zero in the prior year, due primarily to collaborations.
Operating expenses rose to $7.4 million, attributed to increased investments in obesity programs and higher compensation costs.
Net loss widened to $7.3 million, reflecting the absence of prior year's sale gains and ongoing R&D expenditures.
Cash position improved to $14.5 million, providing sufficient runway into FY2027 to advance ongoing clinical programs.

View recap

ReNew Energy Global Plc

RNW Q3 2026

Reported: 2026-02-17

ReNew's Q3 FY26 results reveal significant growth, with adjusted EBITDA up 31% and a sixfold increase in profit after tax, driven by strategic portfolio optimization and advantageous financing conditions.

Key takeaways

Operating capacity increased from 10.7 GW to 11.8 GW, with a 19% net increase year-over-year after accounting for asset sales.
Adjusted EBITDA for the first nine months reached INR 74.8 billion, with profit after tax growing over sixfold.
Successfully raised $600 million via a bond offering, reducing interest rates substantially, resulting in annual savings of approximately $9 million.
Company expects adjusted EBITDA guidance to increase to INR 90 billion to INR 93 billion for the fiscal year, supported by robust manufacturing contributions.
ESG performance remains a priority, achieving top quartile global ratings in climate and water management initiatives.

View recap

Earnings Recaps

Ashmore Group PLC

BlueScope Steel Limited

Canaccord Genuity Group Inc.

RH

Deterra Royalties Limited

HIVE Digital Technologies Ltd.

Macmahon Holdings Limited

Medtronic plc

Palatin Technologies, Inc.

ReNew Energy Global Plc

Community

Trending This Week

Notifications